Cargando…

CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT

Detalles Bibliográficos
Autores principales: Suhren, Jan-Theile, Schlué, Jerome, Kreipe, Hans, Hussein, Kais
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913439/
https://www.ncbi.nlm.nih.gov/pubmed/35179642
http://dx.doi.org/10.1007/s00277-021-04394-2
_version_ 1784667440168304640
author Suhren, Jan-Theile
Schlué, Jerome
Kreipe, Hans
Hussein, Kais
author_facet Suhren, Jan-Theile
Schlué, Jerome
Kreipe, Hans
Hussein, Kais
author_sort Suhren, Jan-Theile
collection PubMed
description
format Online
Article
Text
id pubmed-8913439
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89134392022-03-15 CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT Suhren, Jan-Theile Schlué, Jerome Kreipe, Hans Hussein, Kais Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-02-18 2022 /pmc/articles/PMC8913439/ /pubmed/35179642 http://dx.doi.org/10.1007/s00277-021-04394-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Suhren, Jan-Theile
Schlué, Jerome
Kreipe, Hans
Hussein, Kais
CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
title CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
title_full CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
title_fullStr CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
title_full_unstemmed CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
title_short CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
title_sort cd20/cd79a/pax5/cd3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between ptld and ptsmt
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913439/
https://www.ncbi.nlm.nih.gov/pubmed/35179642
http://dx.doi.org/10.1007/s00277-021-04394-2
work_keys_str_mv AT suhrenjantheile cd20cd79apax5cd3negativeposttransplantlymphomawithaberrantactinanddesmincoexpressionapotentialdifferentialdiagnosticpitfallbetweenptldandptsmt
AT schluejerome cd20cd79apax5cd3negativeposttransplantlymphomawithaberrantactinanddesmincoexpressionapotentialdifferentialdiagnosticpitfallbetweenptldandptsmt
AT kreipehans cd20cd79apax5cd3negativeposttransplantlymphomawithaberrantactinanddesmincoexpressionapotentialdifferentialdiagnosticpitfallbetweenptldandptsmt
AT husseinkais cd20cd79apax5cd3negativeposttransplantlymphomawithaberrantactinanddesmincoexpressionapotentialdifferentialdiagnosticpitfallbetweenptldandptsmt